key: cord-0869008-t194v9ma authors: Matsui, Takemi; Kobayashi, Tsuyoshi; Hirano, Masaya; Kanda, Masahiro; Sun, Guanghao; Otake, Yusuke; Okada, Masakazu; Watanabe, Sadao; Hakozaki, Yuikiya title: A Pneumonia Screening System based on Parasympathetic Activity Monitoring in Non-contact Way using Compact Radars Beneath the Bed Mattress. date: 2020-06-04 journal: J Infect DOI: 10.1016/j.jinf.2020.06.002 sha: 32c058c78f17697a9fdd60087914b14c8d8e1c11 doc_id: 869008 cord_uid: t194v9ma nan which is associated with elevated respiratory rate (RR) and heart rate (HR). Increases in HR are frequently associated with attenuation of parasympathetic nervous function. Here, we propose a novel pneumonia screening system (PSS) to monitor changes in parasympathetic nervous function and vital signs induced by pneumonia pathogenesis 9)-10) . The PSS monitors pneumonia pathogenesis in a non-contact manner (i.e., without using any electrodes) while the patient is lying in a bed. This PSS is composed of a pair of compact Doppler radars (24 GHz, 10 mW micro-output power) installed beneath the bed mattress and pneumonia-screening algorithms ( Figure 1 ). The PSS does not adopt thermography for body temperature measurement, since such individual monitoring over 24 h may raise privacy concerns. The PSS monitors parasympathetic nervous system activation, by means of the high-frequency (HF) component of the heart rate variability (HRV), as well as the HR and RR. The HF is modulated by the vagal tone, which is frequently attenuated as the HR increases. The Mahalanobis' squared distance (MSD), a non-Euclidean distance representing the extent of separation between two groups, is then determined from the three-dimensional distributions of the RR, HR, and HF before and after pneumonia onset 6) . The results shown in Figure 2 indicate that the MSD drastically increases at the moment of pneumonia pathogenesis. Because the vital signs of elderly patients vary between individuals more than among young adults and middle-aged people, we adopted the MSD to determine the optimal screening conditions for elderly patients. The vital signs recorded in 8-hour period are classified into two groups (anterior half 4 hours (before pathogenesis) and latter half 4 hours (after pathogenesis)) to determine the MSD from the RR, HR, and HF values. The PSS algorithms utilize a linear discriminant (LD) function to detect pneumonia pathogenesis from the maximum MSD value and the corresponding RR, HR, and HF of each patient. The Z value of the LD function is expressed as follows: Z = a・MSD + b・ΔRR/Δt +c・ΔHR/Δt + d・ΔHF/Δt + e, where ΔRR/Δt, ΔHR/Δt, and ΔHF/Δt are the rates of change in the parameters over the past 8 hours. We conducted a clinical test of the PSS with 19 chronically ill, bedridden patients without pneumonia (12 females and 7 males aged 42-90 years) for five consecutive days. The participants were recruited at Genkikai Yokohama Hospital. During the clinical testing period, two patients developed pneumonia, as diagnosed by chest X-ray and based on sputum examination. Then, the RR is determined from Wave 2, and the HR is calculated from Wave 3. In addition, the PSS evaluates the time-series heartbeat peak-to-peak (PP) intervals from Wave 3, then the HF component (0.15-0.4 Hz) of the HRV, corresponding to parasympathetic nervous system activity, is obtained by applying an autoregressive (AR) power spectrum density estimation. The system displays the HR and RR of a patient on a monitor at the nurses' station. The PSS system also calculates the Z value of the LD function as follows: When Z is greater than 0, the PSS indicates that pneumonia is suspected. Figure 2 shows the RR, HR, and HF of a patient before and after pneumonia pathogenesis as three-dimensional plots. The left plot depicts the changes before and after pneumonia pathogenesis, and the right plot shows the moment PSS measured upon pneumonia pathogenesis (shadowed area), during the period for this patient. The data show that the RR and HR increase, while HF decreases, indicating attenuation of parasympathetic nervous activity. The most important indices for pneumonia screening, the sensitivity and negative predictive value (NPV), were both 100% for this PSS. Based on these findings, the PSS appears promising for future pneumonia screening, potentially in patients with COVID-19, in hospitals or at home. This system offers unique benefits in healthcare as it does not require the use of electrodes and imposes minimal inconvenience to the examinee. The present study was approved by the ethics committees of Genkikai Yokohama Hospital, Tokyo Metropolitan University, Hino Campus and Konica Minolta, Inc. The authors declare that they have no conflicts of interest. Pneumonia screening system (PSS) composed of two compact Doppler radars (24 GHz, 10 mW micro-output power) installed beneath the bed mattress and pneumonia screening algorithms. Using this system, the PSS monitors the heart rate (HR) and respiratory rate (RR) of a bedridden patient without using any electrodes and displays them at the nurses' station. When Z > 0 (where Z = 0.18・MSD + 0.15・RR/Δt + 0.12・ΔHR/Δt + 0.001・ΔHF/Δt -3), the PSS indicates that the patient is "suspected of pneumonia". The dual radars of the PSS installed beneath the bed mattress monitor Wave 1, which contains both the respiratory component and the heartbeat component. The PSS then separates Wave 1 into Wave 2 (the respiratory component) and Wave 3 (the heartbeat component). The RR is determined from Wave 2, and the HR and HF of the heart rate variability (HRV) are calculated from Wave 3. Left: Three-dimensional plots of heart rate (HR), respiratory rate (RR), and HF (representing parasympathetic nervous activity) before and after pneumonia pathogenesis (i.e., pneumonia unsuspected and suspected, respectively). Right: The moment of pneumonia pathogenesis in a patient (shadowed area) identified by the PSS; at this point, the RR and HR increase, and the parasympathetic nervous activity decreases (represented by an increase in the HR). A novel machine-learning-based infection screening system via 2013-2017 seasonal influenza patients' vital-signss as training datasets Field evaluation of an infectious disease/fever screening radar system during the 2017 dengue fever outbreak in Hanoi, Vietnam: a preliminary report Clinical evaluation of the newly developed infectious disease/fever screening radar system using the neural network and fuzzy grouping method for travellers with suspected infectious diseases at Narita International Airport Clinic An infectious disease/fever screening radar system which stratifies higher-risk patients within ten seconds using a neural network and the fuzzy grouping method A novel infection screening method using a neural network and k-means clustering algorithm which can be applied for screening of unknown or unexpected infectious diseases A novel screening method for influenza patients using a newly developed non-contact screening system Disease burden by Cause, Age, Sex, by Country and by Region The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response A novel regulator of lung inflammation and immunity: pulmonary parasympathetic inflammatory reflex Development of a practicable non-contact bedside autonomic activation monitoring system using microwave radars and its clinical application in elderly people The author sincerely thanks Ms. Saeko Nozawa for her contributions to manuscript preparation and revision and Ms. Yoko Kato for her support in drawing figures. We thankStephanie Knowlton, PhD, from Edanz Group (https://en-author-services.edanzgroup.com/) for editing a draft of this manuscript.